We’re proud to announce our most advanced Swoop® system yet is #FDACleared—a portable #MRI powered by Optive AI™ software. It’s a transformative leap in image quality, workflow, and comfort, redefining what’s possible with portable brain imaging. #MedTech https://t.co/czOQ3zJ0mH
#NEWS! Hyperfine advances international Swoop® system Model 2 rollout and highlights the role of #portableMRI in #brainhealth awareness. Our latest Optive AI™ software has received CE mark and UKCA approvals as #SwoopSystem Model 2 reaches four international markets just a few months after approval. #Hyperfine is proud to support and be showcased in Notes and Neurons: Music for Brain Health, a nationwide German initiative bringing together musicians, neuroscientists, and clinicians for six symphonic performances featuring live, on-stage scanning with the Swoop system to explore the connection between music, memory, emotion, and brain function. Read full release https://t.co/p8irxcgOHy
#MedTech
Seattle, we’re headed your way! The #Hyperfine team will be at #NCS2026 this week, and we’re looking forward to connecting with the #neurocriticalcare community. Join us to explore how the #SwoopSystem brings brain MRI to the bedside—and share your perspective on the imaging challenges you face in the ICU. Attending? Let’s connect! Visit Hyperfine Booth 307
#NEWS! Hyperfine reports record preliminary third quarter revenue of approximately $6M and reaffirms full year 2026 revenue outlook of approximately $20-$22M. Read full press release https://t.co/BQAL532F65
#Hyperfine#SwoopSystem#MedTech#PortableMRI
When #stroke is suspected, timely imaging can help guide critical care decisions. In this case, a 63-year old patient presented to the ED with suspected stroke. The Swoop® system was driven to the patient's bedside and ready to scan within minutes following an inconclusive CT scan. The Swoop system images allowed clinicians to confirm a right anterior choroidal infarct. Thrombolytic therapy was administered, and patient was transferred to stroke unit for monitoring and management. If you’re heading to #ACEP26 in Chicago Oct 5-7, let’s discuss the role of portable brain MRI in #emergencycare. Visit Hyperfine Booth 4220
#Hyperfine #PortableMRI #MedTech
A review in Nature Reviews Neurology explores how low-field #MRI could bring dementia-relevant imaging beyond specialized centers and into community settings. Dementia burden is projected to rise in low- and middle-income countries, where MRI access per capita is lowest. India has fewer than 0.3 MRI scanners per million people while the U.S. and Japan have 30-50 per million. This #HealthyAgingMonth, we're inspired by innovations that expand access and help make brain health assessment possible in more communities around the world. Link to article https://t.co/uxSJuBWId0 #PortableMRI #BrainHealth #GlobalHealth
Is your ED overflowing because MRI is backed up? At #ACEP26, learn how the Swoop® portable MRI system is already being used in emergency care. From clinical data to real-world ED experience, see how portable brain MRI fits into ED workflows, delivers clinically meaningful imaging, and has the potential to support faster care decisions. Visit Hyperfine Booth 4220 Oct 5-7 at McCormick Place, Chicago. See you there! #EmergencyMedicine #PortableMRI #Hyperfine #SwoopSystem
#NEWS! #Hyperfine expands global access to portable MRI across the Gulf Cooperation Council (GCC) Region by appointing Roots Pharmaceutical Co. W.L.L. as exclusive distributor of the Swoop® system for the UAE and Kuwait. This partnership represents an important step in our international growth strategy and reflects our commitment to expanding access to brain imaging technologies globally. Read the full press release https://t.co/XX0lGVkBXS
#PortableMRI #SwoopSystem #MedTech #GlobalHealth
#NEWS: #Hyperfine has completed patient enrollment in the Contrast PMR study evaluating contrast-enhanced ultra-low-field portable MRI with the Swoop® system. The study assesses the system's ability to visualize common contrast-enhancing brain lesions using standard gadolinium-based contrast agents. If the indication for use with contrast-enhancing agents were granted, bringing this capability to portable MRI has the potential to expand use in outpatient settings and open new applications for post-procedural imaging in surgical environments, including assessment of residual tumor after resection. As image review and data analysis begin, we're targeting a planned FDA 510(k) submission by the end of 2026. See full press release https://t.co/nMS7bKqu5r #MedTech #HealthCareNews
The Swoop® system goes where conventional MRI can’t. Care environments like #ICUs and emergency departments are filled with equipment that can create electromagnetic interference—invisible noise that can affect MRI image quality. That’s where the #SwoopSystem’s upgraded noise-canceling “headphones” come in. The latest advancement in Optive AI™ software takes #Hyperfine’s proprietary noise cancellation a step further, improving noise correction across all sequences to help deliver clearer, diagnostic-quality brain images – even in the noisy point-of-care environments where only the Swoop system can go. #ICYMI see #pressrelease https://t.co/neBUjD9Ofv
#MedTech #PortableMRI
#NEWS! NEURO PMR results are now published in the Journal of Neuroimaging as the Swoop® system surpasses 3,000 brain MRI scans across physician practices in its first year. The Swoop system is being used across general neurology, headache, memory, pediatric neurology, concierge medicine, and longevity practices—bringing brain imaging closer to where patients receive their everyday care. Read full press release https://t.co/1xFyqV3jOp
#Hyperfine #MedTech #PortableMRI #SwoopSystem
#NEWS! #Hyperfine announces FDA clearance of the Next Optive AI™ software update for the Swoop® system that delivers improved image quality across all sequences, a more intuitive scanning experience, and new foundational isotropic imaging designed to strengthen the clinical utility of portable MRI.
Read full press release https://t.co/Bwfnx848WZ
#MedTech #PortableMRI #SwoopSystem
#NEWS! #Hyperfine announces the release of multiple peer-reviewed publications in Stroke and the Journal of Neurosurgery, expanding evidence for the Swoop® system in multiple sites of care. The collection of publications in Stroke added to the growing body of evidence supporting the value of low-field MRI across the stroke continuum. In the published endovascular neurosurgical procedure cases, the Swoop system provided immediate post-procedure access to imaging, which enabled same-day discharge.
These publications add to a substantial clinical foundation: 180+ peer-reviewed publications and 280+ scientific presentations spanning multiple sites of care in support of imaging for a broad range of clinical conditions.
Link to full press release https://t.co/oseHtWbihp
#SwoopSystem #PortableMRI #MedTech
#NEWS! #Hyperfine continues to execute on global expansion with the European launch of the Next-Generation Swoop® system powered by the latest advancement in Optive AI™ software. Following CE mark and UKCA approval of the next-generation Swoop® system, also known as Model 2, the system is now commercially available across an initial wave of European markets. France’s central purchasing body has added the Model 2 to its procurement list—unlocking broader adoption across the public healthcare system. This milestone builds on strong momentum, including Hyperfine’s recent inclusion in the Russell 2000®, as the company continues scaling global access to AI-powered portable MRI. Read full press release https://t.co/oHexNydGJo #PortableMRI #MedTech #AIinHealthcare
Congratulations to Dr. Alicia Cabrera of Neurology of Central Florida and her team on reaching an incredible milestone—500 patients scanned with the Swoop® system.
Every scan represents a patient who gained access to brain imaging closer to the point of care, helping support faster clinical decision-making and a more comfortable patient experience.
#Neurology #PortableMRI #Hyperfine #SwoopSystem
#NEWS: Hyperfine has formed a Neurosurgery Advisory Council, bringing together leading neurosurgeons from top institutions around the world to help shape the future of portable MRI in neurosurgical care. By convening leading neurosurgeons across subspecialties and care settings, Hyperfine aims to accelerate the evaluation of portable MRI in neurosurgical workflows and help expand the clinical utility of the Swoop® system in this important area of care.
🔗 Read more: https://t.co/fr7ewalUU7
#Hyperfine #SwoopSystem #PortableMRI #Neurosurgery
Hear more from two of these centers featured in our recent webinar on how portable MRI is transforming stroke care. Link to webinar https://t.co/dtl32OUQPO
#NEWS: #Hyperfine announces Swoop® system scan volume hitting record milestones with expansion into new sites of care and broadening clinical applications. Increasing clinical use of the #SwoopSystem is driven by enhanced clinical utility from improved image quality, growing evidence of its economic value, and expanding adoption across new care settings, including neurology clinics and the emergency department. Read full press release https://t.co/lgrDsHde9M
#PortableMRI #MedTech
Thank you to everyone who connected with us during the American Headache Society Annual Scientific Meeting. We had meaningful conversations about the role of neuroimaging in headache care and the opportunity to bring imaging closer to the point of care.
As Migraine & Headache Awareness Month continues, we’re grateful to be part of the conversation around improving access, supporting clinicians, and helping patients move from uncertainty to answers faster.
In case you missed out, check out our recent article on how neurologists can integrate imaging as an extension of the neurologic exam.
https://t.co/muuoiNPXuh
#AHS2026 #HeadacheMedicine #MigraineAwarenessMonth #Neurology #PortableMRI #Neuroimaging #Hyperfine #SwoopSystem
This week, CEO Maria Sainz presented at the Jefferies Global Healthcare Conference in New York, sharing Hyperfine's vision for expanding access to MRI around the world.
MRI remains one of the most valuable diagnostic tools in medicine, yet many patients continue to face barriers to access due to infrastructure, cost, workflow, and geographic limitations.
At Hyperfine, we're working to change that.
By commercializing our proprietary portable MRI technology, we're helping clinicians and healthcare providers broaden access to MRI for patients suffering from debilitating neurological conditions such as stroke and dementia.
As we continue to grow, we remain focused on advancing innovation, supporting clinicians, and building a business that expands access to MRI globally.
Thank you to @Jefferies for hosting a great event and to everyone who took the time to meet with our team this week.
#Hyperfine #SwoopSystem #PortableMRI #MRI #HealthcareInnovation #Neurology #StrokeCare #DementiaCare #MedTech
A year ago Hyperfine received FDA clearance for the next-generation Swoop® system powered by Optive AI™ software—delivering a transformative leap to image quality. In the past 12 months:
✓ Expanded US commercial deployments of the next-generation Swoop® system in hospitals and neurology practices, including headache and wellness clinics.
✓ Broadened global access to Optive AI™, the most substantial image quality improvement to date for the Swoop® system—dramatically elevating image quality at ultra-low field strength, enabling more confident diagnoses at the point of care.
✓ FDA clearance of a major Optive AI™ update with advanced DWI capabilities that delivers substantially improved image quality and diagnostic confidence for stroke detection, supported by compelling clinical evidence published in Society of Vascular and Interventional Neurology (SVIN).
✓ Neurosurgery emerging as a use case for portable MRI enabling real-time imaging that can support faster neurosurgical decision-making without interrupting workflow or requiring patient transport.
✓ Achieved CE Mark and UKCA approval, bringing our latest technology to clinicians and patients across Europe and the United Kingdom.
What makes this milestone especially meaningful is that it reflects the work of clinicians, researchers, customers, partners, and all of us at Hyperfine who believe that access to MRI should not be limited by geography, infrastructure, or patient mobility.
Thank you to everyone who has been part of this journey. The first year of the next-generation Swoop® system was just the beginning.
#Hyperfine #Swoopsystem #PortableMRI